St Jude explores migraine market for heart defect repair tool and asseses broader CRT use
This article was originally published in Clinica
Executive Summary
St Jude Medical has joined the race to take a catheter-based heart defect repair tool to the migraine headache market. And in a separate announcement, the company said it was exploring the possibility of expanding the indications for its cardiac resynchronisation therapy (CRT) devices for treating heart failure (HF).